Malignant Germ Cell Tumor — Trials

Malignant Germ Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

114 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 44
Recruiting: 22
Ph III recruiting: 2
Growth YoY: —
Industry share: 2%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–27 of 27 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07705035	DBC-664 in Adult Patients With Solid Tumors	recruiting	Phase 1	210	Duboce Biopharmaceuticals, Inc.INDUSTRY	1	Sep 29, 2026	clinicaltrials
NCT04684368	A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT	recruiting	Phase 2	160	Children's Oncology GroupNETWORK	4	Sep 23, 2026	clinicaltrials
NCT05529251